[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @StreetCred2017 @StreetCred2018 @StreetCred2018 posts on X about $amgn, $ifrx, rates, upside the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::949761349197864960/interactions)  - X Week XXX -XX% - X Month XXXXXX +53% - X Months XXXXXX -XX% - X Year XXXXXXXXX +106% ### Mentions: X [#](/creator/twitter::949761349197864960/posts_active)  - X Week XX -XX% - X Month XX +41% - X Months XXX -XX% - X Year XXX +59% ### Followers: XXX [#](/creator/twitter::949761349197864960/followers)  - X Week XXX +0.36% - X Month XXX +0.61% - X Months XXX +13% - X Year XXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::949761349197864960/influencer_rank)  ### Social Influence [#](/creator/twitter::949761349197864960/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [finance](/list/finance) XXXX% **Social topic influence** [$amgn](/topic/$amgn) 3.13%, [$ifrx](/topic/$ifrx) 2.08%, [rates](/topic/rates) 1.04%, [upside](/topic/upside) 1.04%, [finance](/topic/finance) 1.04%, [wld](/topic/wld) 1.04%, [versa](/topic/versa) 1.04%, [insurance](/topic/insurance) XXXX% **Top accounts mentioned or mentioned by** [@quick2smile](/creator/undefined) [@o248528307](/creator/undefined) [@3in5saved](/creator/undefined) [@maximusholla](/creator/undefined) [@rdd147](/creator/undefined) [@dogtor01416800](/creator/undefined) [@kobeissiletter](/creator/undefined) [@biopharmiq](/creator/undefined) [@semodough](/creator/undefined) [@biovalues](/creator/undefined) [@peterschiff](/creator/undefined) [@elonmusk](/creator/undefined) [@billackman](/creator/undefined) [@realdonaldtrump](/creator/undefined) [@zerohedge](/creator/undefined) [@cdcdirector](/creator/undefined) [@cdcgov](/creator/undefined) [@fdacderdirector](/creator/undefined) [@usdafoodsafety](/creator/undefined) [@biotechsanya2](/creator/undefined) **Top assets mentioned** [Amgen, Inc. (AMGN)](/topic/$amgn) ### Top Social Posts [#](/creator/twitter::949761349197864960/posts) --- Top posts by engagements in the last XX hours "@Quick2smile @ANKITSH85153215 Interesting and I think Inflarx did same thing w cSCC At end of the day it (C5a antagonist) may wind up being used in combination w some chemo agent. $AMGN $IFRX #PancreaticCancer needs anything that improves XX% survival rates. Compassionate use" [X Link](https://x.com/StreetCred2017/status/1975181788009115894) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-06T12:50Z XXX followers, XXX engagements "@biotechsanya2 Also avacopan is approved for AAV so not exactly a failure for $AMGN but assume youre talking about the P1 Inflarx comparison of INF904 v avacopan" [X Link](https://x.com/StreetCred2017/status/1978589499119604212) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-15T22:31Z XXX followers, XXX engagements "@biotechsanya2 Not sure if this helps comparing $AMGN avacopan v INF904 $IFRX" [X Link](https://x.com/StreetCred2017/status/1978605196461695371) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-15T23:33Z XXX followers, XXX engagements "@Investorclimber @Biotech_AI Gents - any best guess on upside with only X of X showing promise VS both CSU Yes HS -No: or visa versa Guggenheim called 5-10x but seems overly optimistic given need to finance P2b but both wld show pipeline potential. Also partner needed" [X Link](https://x.com/StreetCred2017/status/1978425820487069859) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-15T11:40Z XXX followers, XXX engagements "@3in5saved Still we need fda to say yes - or insurance willing to pay to use Gohibic off label -" [X Link](https://x.com/StreetCred2017/status/1979586654152098003) [@StreetCred2017](/creator/x/StreetCred2017) 2025-10-18T16:33Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@StreetCred2018 posts on X about $amgn, $ifrx, rates, upside the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks XXXX% finance XXXX%
Social topic influence $amgn 3.13%, $ifrx 2.08%, rates 1.04%, upside 1.04%, finance 1.04%, wld 1.04%, versa 1.04%, insurance XXXX%
Top accounts mentioned or mentioned by @quick2smile @o248528307 @3in5saved @maximusholla @rdd147 @dogtor01416800 @kobeissiletter @biopharmiq @semodough @biovalues @peterschiff @elonmusk @billackman @realdonaldtrump @zerohedge @cdcdirector @cdcgov @fdacderdirector @usdafoodsafety @biotechsanya2
Top assets mentioned Amgen, Inc. (AMGN)
Top posts by engagements in the last XX hours
"@Quick2smile @ANKITSH85153215 Interesting and I think Inflarx did same thing w cSCC At end of the day it (C5a antagonist) may wind up being used in combination w some chemo agent. $AMGN $IFRX #PancreaticCancer needs anything that improves XX% survival rates. Compassionate use"
X Link @StreetCred2017 2025-10-06T12:50Z XXX followers, XXX engagements
"@biotechsanya2 Also avacopan is approved for AAV so not exactly a failure for $AMGN but assume youre talking about the P1 Inflarx comparison of INF904 v avacopan"
X Link @StreetCred2017 2025-10-15T22:31Z XXX followers, XXX engagements
"@biotechsanya2 Not sure if this helps comparing $AMGN avacopan v INF904 $IFRX"
X Link @StreetCred2017 2025-10-15T23:33Z XXX followers, XXX engagements
"@Investorclimber @Biotech_AI Gents - any best guess on upside with only X of X showing promise VS both CSU Yes HS -No: or visa versa Guggenheim called 5-10x but seems overly optimistic given need to finance P2b but both wld show pipeline potential. Also partner needed"
X Link @StreetCred2017 2025-10-15T11:40Z XXX followers, XXX engagements
"@3in5saved Still we need fda to say yes - or insurance willing to pay to use Gohibic off label -"
X Link @StreetCred2017 2025-10-18T16:33Z XXX followers, XX engagements
/creator/twitter::StreetCred2017